Home / Resources / The Annual Clinical Trials Roundup
WHITE PAPER

The Annual Clinical Trials Roundup

This report focuses on an overview of Phase I–III clinical trials that initiated in 2022 across all therapeutic areas, as well as in-depth analyses into the key diseases, players, and geographies that impact the pharmaceutical industry. In 2022, the roller coaster resumed as the healthcare industry continued to be influenced by the global economy and political climate.

Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.
Related products
Surfacing insights for a successful clinical trial
Trialtrove
臨床試験の戦略、設計、実施のための頼りになる情報リソース
Building a data driven site and investigator selection model
Sitetrove
グローバルな臨床試験の治験責任医師と治験実施施設の情報を提供する、業界をリードするスイート
Getting the full drug RandD landscape
Pharmaprojects
世界的な医薬品研究開発の状況を追跡し、分析するための業界標準

Related resources

PDF preview of the 2022 Clinical Trials Roundup Overview infographic.
NOV 03, 2023
Infographic
Clinical

Phase I-III Clinical Trials Overview

This overview shares key insights from our roundup report on Phase I–III clinical trials that initiated in 2022 across all therapeutic areas.

a man and woman in white coat looking at a computer screen
MAY 01, 2023
Whitepaper
Clinical

2022 Completed Trials: A Roller Coaster Ride for Industry Sponsors

In 2022, Trialtrove recorded 3,881 industry-sponsored Phase I-IV clinical trials that either reached completed status or reported primary endpoints.

''
APR 01, 2023
Whitepaper
Clinical

Citeline Pharma R&D Annual Review 2023

The Pharma R&D Annual Review 2023 assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

View all resources